Haemotology Week 4 - Macrocytic Anaemia, Megaloblastic Anaemia, Haemoglobinopathies

Macrocytic Anaemia

  • Macrocytic anaemia: RBCs are abnormally large; defined by \text{MCV} > 97\,\text{fL}.
  • Major categories:
    • Megaloblastic macrocytic anaemia (B12 or folate deficiency).
    • Non-megaloblastic macrocytosis (e.g., liver disease, alcoholism, pregnancy, cytotoxic drugs).
  • Other macrocytic considerations listed in lecture include oval RBCs, erythroblasts in bone marrow with abnormal maturation, reticulocytosis, myeloma, myelodysplasia, aplastic anaemia.

Megaloblastic Anaemia

  • Megaloblastic anaemia is characterised by abnormal erythroblasts in the bone marrow with asynchronous maturation of cytoplasm and nucleus (delayed maturation).
  • Common causes:
    • Vitamin B12 (cobalamin) deficiency.
    • Folate deficiency.
    • Metabolic abnormalities of B12 or folate (rare).
  • Clinical features include jaundice, oral/skin manifestations, and weight changes (see below).

Megaloblastic Anaemia: Clinical Features

  • Icterus (jaundice).
  • Angular cheilosis (sore corners of mouth).
  • Glossitis.
  • Weight loss.
  • Purpura (rare).
  • Hyperpigmentation (rare).
  • Source: Hoffbrand’s Essential Haematology, 7th Ed.

Neural Tube Defects (NTDs) and Folate/B12

  • Folate or B12 deficiency in the mother predisposes the fetus to neural tube defects (anencephaly, spina bifida, encephalocoele).
  • Lower maternal serum/red cell folate or serum B12 increases NTD incidence.
  • Importance of folic acid/B12 supplementation at conception and early pregnancy.

Vitamin B12 (Cobalamin)

  • Role: B12 is a coenzyme for methionine synthase, required for folate activation; essential for DNA synthesis.
  • Daily requirement: 1μg/day1\,\mu\text{g/day} (normal mixed diet provides 1015μg/day10-15\,\mu\text{g/day}).
  • Body stores: stored in liver, lasts 24 years2-4\text{ years}.
  • Consequence of deficiency: megaloblastic anaemia.

Vitamin B12 – Biochemical basis

  • B12 is required for conversion of methyl-THF to THF, enabling thymidine synthesis and DNA replication.
  • In deficiency, the methyl-THF trap leads to impaired DNA synthesis and megaloblastic changes.
  • Key reaction (cobalamin-dependent):
    Homocysteine+5-methyl-THFB12THF+Methionine\text{Homocysteine} + \text{5-methyl-THF} \xrightarrow{\text{B}_{12}} \text{THF} + \text{Methionine}
  • This links B12 to folate utilization for DNA synthesis.

Vitamin B12 Absorption

  • Dietary B12 binds intrinsic factor (IF) produced by gastric parietal cells.
  • IF–B12 complex is absorbed in the ileum.
  • Absorbed B12 binds to transcobalamin II (TC-II) to deliver to bone marrow and other tissues.
  • Most B12 is bound to an inactive carrier (TC-I).

Folate

  • Folate is a coenzyme for thymidylate monophosphate (dTMP) synthesis, essential for DNA synthesis.
  • Daily requirements: ~100μg100\,\mu\text{g} (diet provides 200-250\,\mu\text{g}, ~50\% absorbed}).
  • Body stores: ~4 months.
  • Dietary folate absorbed in duodenum/jejunum; absorbed as methyl-tetrahydrofolate (methyl-THF) in plasma; inside cells converted to folate polyglutamates for use.
  • Absorption/activation diagram note: polysaccharide forms are converted to active polyglutamates for intracellular use.

B12 / Folate Absorption and Interplay

  • Folate polyglutamates are absorbed after dietary folate is converted to methyl-THF in plasma.
  • B12 indirectly supports folate utilization by regenerating THF from methyl-THF, enabling dTMP synthesis.
  • Illustration concept (from lecture): B12 -> THF regeneration -> DNA synthesis (dTMP).

B12 Deficiency: Causes

  • Inadequate diet.
  • Malabsorption (e.g., pernicious anaemia, gastrectomy, congenital IF deficiency).
  • Intestinal causes (fish tapeworm, bacterial colonisation, ileal resection, congenital B12 malabsorption with proteinuria).
  • Helicobacter pylori infection and gluten-induced enteropathy.

Pernicious Anaemia

  • Autoimmune attack on gastric mucosa causing destruction of gastric parietal cells and antibodies against IF.
  • Result: lack of intrinsic factor (IF) and impaired B12 absorption.
  • Serology positives include:
    • Parietal cell antibody.
    • IF-blocking antibody (Type I).
    • IF-precipitating antibody (Type II).

Hydroxocobalamin Therapy (B12 deficiency treatment)

  • Therapy: hydroxocobalamin 1 mg intramuscularly.
  • Effect on haematology markers (example data from figure): isolation of reticulocytes rise after treatment; other counts (WBC, Hb, platelets) show improvement over time.

Folate Deficiency

  • Causes:
    • Malnutrition.
    • Malabsorption.
    • Excess utilization (pregnancy, lactation, hematologic/malignant diseases, inflammatory diseases).
    • Urinary loss.
    • Drugs.
    • Other (liver disease, alcoholism).

B12 / Folate Deficiency – Clinical Features

  • Gradual onset anaemia.
  • Mild jaundice.
  • Glossitis; sore corners of mouth; sterility in severe cases.
  • Neuropathy (B12 deficiency).
  • Fetal neural tube defect risks with maternal deficiency.
  • Often asymptomatic in some cases.

Laboratory Findings in B12 vs Folate Deficiency

  • Macrocytic anaemia with oval macrocytes.
  • Hypersegmented neutrophils (>5 lobes).
  • Possible leukopenia and thrombocytopenia in severe cases.
  • Bone marrow: hypercellular; erythroblasts large with immature nuclei.
  • Biochemical markers: ↑ serum bilirubin and ↑ lactate dehydrogenase (LDH).
  • Serum tests:
    • B12 deficiency: low serum B12; folate status variable; RBC folate decreased in folate deficiency.
    • Folate deficiency: low serum and/or red cell folate.
  • Treatments:
    • B12 deficiency: hydroxocobalamin (or cyanocobalamin).
    • Folate deficiency: folic acid supplementation.

Other Megaloblastic Anaemias

  • Other causes include:
    • Congenital defects in enzymes involved in B12/folate metabolism.
    • Transcobalamin deficiencies.
    • Nitrous oxide exposure.
    • Antifolate drugs (e.g., methotrexate, primethamine, trimethoprim).

Other Macrocytic Anaemias

  • Other macrocytic anaemias (>97 fL) not due to megaloblastic processes include:
    • Alcohol use.
    • Liver disease.
    • Hypothyroidism.
    • Reticulocytosis.
    • Cytotoxic drugs.
    • Myelodysplastic syndromes.
    • Pregnancy.
    • Smoking.
    • Myeloma and paraproteinaemia.
    • Neonatal states.

Haemoglobin Basics

  • Hb is composed of two pairs of globin chains: \text{Hb} = (\alpha1\beta1)(\alpha2\beta2) attached to haem.
  • Quaternary structure enabling transport of O2 and CO2; also carries nitric oxide (NO).
  • ~640\times 10^6 Hb molecules per RBC.
  • Fully loaded Hb can carry up to 4 O2 molecules.
  • In deoxygenated Hb, the β chains undergo conformational changes allowing 2,3-DPG to enter and decrease Hb affinity for O2 (rightward shift).
  • Normal Hb-O2 dissociation curve is modulated by 2,3-DPG, H+, CO2, and Hb structure.
  • Right shift (P50 up) indicates decreased affinity; left shift (P50 down) indicates increased affinity. Examples: Hb S (right shift) vs Hb F (left shift).

Normal Haemoglobins

  • Foetal Hb (Hb F): Predominant in fetus; composition \text{Hb F} = \alpha2\gamma2; higher O2 affinity facilitates maternal transfer.
  • Adult Hb types:
    • Hb A: \alpha2\beta2 (predominant).
    • Hb A2: \alpha2\delta2$$ (small amounts).
    • Hb F: small amounts postnatally; gamma chain declines after birth (3–6 months transition to beta).
  • Other developmental Hb types include Gower and Portland during fetal development.

Haemoglobinopathies

  • Definition: disorders due to abnormal Hb structure or reduced synthesis of normal globin chains (alpha or beta) (i.e., thalassaemias).
  • Major Hb variants include: Hb S (sickle), Hb C, Hb D, Hb E, and many others (>1000 globin gene mutations reported).
  • Classification summary:
    • Unstable or crystalline Hb (e.g., Hb S, C, D, E).
    • Thalassaemias (reduced globin chain synthesis).
    • Sickle cell disease/trait.
    • Methaemoglobinaemia (Hb M).
    • Other variants and clinical syndromes.
  • Geographical distribution of thalassaemias and Hb abnormalities (as per lecture illustration).

Investigations of Hb Variants

  • Full blood count (FBC) with Hb and RBC indices to screen for thalassaemias and structural variants.
  • Blood film may show characteristic changes:
    • Target cells in HbC trait.
    • Sickle cells in HbS disease.
    • Irregularly contracted RBCs in HbC or unstable Hb.
  • Reticulocyte count (indicator of marrow response).
  • Diagnostic tests to confirm Hb variants include:
    • High-performance liquid chromatography (HPLC).
    • Capillary electrophoresis (CE).
    • Cellulose acetate electrophoresis (CAE).
    • Isoelectric focusing (IEF).
    • Sickle solubility test.

Sickle Solubility Test

  • Used to differentiate HbS from HbD or HbG on cellulose acetate electrophoresis;
    • HbS is insoluble in deoxygenated state; crystals form and refract light, giving turbidity.
  • A positive sickle solubility test supports presence of HbS; confirmation by HPLC or IEF.

HPLC for Hb Diagnosis

  • HPLC is used as a first-line method to diagnose Hb disorders.
  • Different Hb types elute at characteristic times on the column; their concentrations are measured.
  • Example: a patient carrier of sickle cell disease shows distinct Hb A, Hb S peaks.

Hb Electrophoresis Patterns

  • Pattern interpretation examples:
    • Normal or α-thalassaemia trait: Hb A with possibly Hb A2 and Hb F patterns.
    • Sickle cell trait: Hb A and Hb S bands.
    • Sickle cell disease: predominantly Hb S with reduced Hb A; presence of Hb F may vary.
    • β-thalassaemia trait: elevated Hb A2 and sometimes Hb F.
    • β-thalassemia major: little or no HbA, predominantly HbF, with possible Hb A2.
    • Sickle cell/β-thalassemia major; Sickle cell/Hb C disease; Hb H disease (rare, in α-thalassaemia contexts).

Methaemoglobinaemia

  • Methaemoglobinaemia: Hb iron in the oxidised Fe^{3+} state rather than Fe^{2+}.
  • Causes: deficiency of methaemoglobin reductase, Hb M variants, exposure to oxidising substances.
  • Clinical feature: cyanosis due to reduced oxygen delivery.

α-Thalassaemia

  • Cause: deletion of α-globin gene(s), reducing α-chain synthesis.
  • Normal α-globin gene dosage: 4 copies (αα/αα).
  • Clinical severity depends on number of missing/inactive genes:
    • Loss of all 4 genes (--/--) → hydrops fetalis (incompatible with life).
    • Loss of 3 genes (--/-α) → HbH disease (adult) or Hb Bart’s (fetal) → severe microcytic, hypochromic anaemia with splenomegaly.
    • Loss of 1 or 2 genes → α-thalassaemia trait; usually no severe anaemia but reduced MCV/MCH; DNA analysis may be needed for diagnosis.
  • Figures show HbH disease and supravital stain (golf ball cells).

β-Thalassaemia

  • Cause: deletion or mutation in β-globin gene leading to reduced β-chain synthesis.
  • β-Thalassaemia major: severe microcytic, hypochromic anaemia; little or no HbA; predominantly HbF; clinical features include growth issues, bone expansion, splenomegaly, hepatomegaly.
  • β-Thalassaemia trait: asymptomatic; common in certain populations; lab features include microcytosis and hypochromasia; elevated HbA2 and variable HbF by HPLC.

Hb S (Sickle Cell Disease) – Overview

  • HbS results from a mutation in the β-globin chain causing structural abnormality.
  • In oxygenated form, HbS is soluble; upon deoxygenation, HbS polymerises, distorting RBCs to a sickle shape.
  • Sickle cell trait (heterozygous): usually asymptomatic but may show sickling under extreme conditions.
  • Sickle cell disease (homozygous HbS): severe haemolytic anaemia with vaso-occlusive crises.

Sickle Cell Disease – Lab and clinical features

  • At birth: normal blood count; in first year, HbF is replaced by HbS; decreased Hb; increased reticulocytes (5–20%).
  • Adult: Hb typically 60–100 g/L; marked fall during crises.
  • Blood film features: sickled cells, target cells, Howell-Jolly bodies, polychromasia, irregularly contracted RBCs, and sometimes blister cells.
  • Sickle cell trait: MCV and MCH usually normal; may be reduced if coexisting α-thalassemia trait.

Sickle Cell Crises and Complications

  • Vaso-occlusive crisis: triggered by infection, dehydration; infarcts cause severe pain in bones/soft tissues (bones, lungs, spleen, brain).
  • Visceral sequestration crisis: sickling within organs with pooling of blood → anaemia, possible acute chest syndrome, splenic sequestration.
  • Aplastic crisis: transient cessation of erythropoiesis.
  • Haemolytic crisis: rapid RBC destruction.
  • Other complications: leg ulcers, pulmonary hypertension, hepatic dysfunction, gallstones, kidney infarctions/dysfunction, osteomyelitis; may require exchange transfusion and risk iron overload.
  • Growth retardation and osteonecrosis are noted.

Sickle Cell Disease – Pattern and Imagery

  • The sickle polymer formation underlies the pathophysiology of crises and organ damage.
  • Visuals depict presentation in pediatric and young adult patients (painful dactylitis, facial changes, etc.).

Review / Practice Prompts

  • Macrocytic anaemias are characterised by increased RBC size (MCV > 97 fL). In B12 or folate deficiency, the bone marrow contains megaloblastic erythroblasts with asynchronous cytoplasmic/nuclear maturation and delayed nuclear maturation due to impaired DNA synthesis.
  • Major differential diagnoses for macrocytosis include liver disease, alcoholism, hypothyroidism, reticulocytosis, cytotoxic drugs, myelodysplastic syndromes, pregnancy, and smoking.
  • B12 deficiency is usually caused by B12 malabsorption due to pernicious anaemia, with antibodies directed against gastric parietal cells or intrinsic factor; resulting in deficiency of intrinsic factor, which is essential for B12 absorption in the gut.
  • Dietary folates are converted to methyl-THF; B12 is required to convert methyl-THF back to THF, enabling DNA synthesis.
  • Hb is composed of two α/β globin pairs and a heme group; Hb has a quaternary structure and transports O2/CO2; a fully loaded Hb can carry 4 O2 molecules.
  • Hb types: Foetal Hb (Hb F) is mainly α2γ2 with higher O2 affinity to support placental transfer; Adult Hb A is α2β2; Hb A2 is α2δ2; Hb F declines after birth as γ is replaced by β.
  • Haemoglobinopathies include thalassaemias (reduced globin synthesis) and Hb variants such as Hb S; diagnosis relies on FBC, smear, HPLC, CE, CAE, IEF, and sickle solubility tests; Hb electrophoresis patterns help distinguish conditions (HbS, HbC, HbD, HbE, β-thal traits/full disease, Hb H disease, etc.).
  • Sickle cell disease features a spectrum of crises: vaso-occlusive, splenic sequestration, aplastic crisis, and hemolytic crises; other complications include growth abnormalities, osteonecrosis, infections, and organ dysfunction.

A Question to Ponder

  • What are these? Clue: a type of body fluid, collected over the recovery period of a condition we will learn about next week.